Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 34, Issue 11, Pages 629-636Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2013.09.008
Keywords
inflammation; innate immunity; therapeutic; atheroma
Categories
Funding
- European Collaborative Project [EU-HEALTH-2007-2.4.2-1.2008]
- British Heart Foundation
- European Commission
- Graham-Dixon Charitable Trust
- Kennedy Trustees
- Arthritis Research Campaign
Ask authors/readers for more resources
Seminal research over the past 20 years has revealed atherosclerosis to be a chronic inflammatory process that shares features with traditional inflammatory diseases including rheumatoid arthritis. More recently, emphasis has been placed on the role of innate immunity in the development and progression of atherosclerosis. In particular, pattern recognition receptors, including Toll-like receptors (TLRs), have been the focus of much attention as modulators of atherogenesis. This review provides an update on the developments in this area of research in the past 2 years, with a specific focus on the current controversies and how these may affect the design of therapeutics. Specifically, we will address the recent evidence that TLRs elicit both protective and detrimental effects in atherosclerosis and the emerging observation that the outcome of TLR signaling is dependent on the agonist and responding cell type.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available